CORRECTING AND REPLACING – Aravive Announces Participation at Cowen and Company 39th Annual Health Care Conference

NEXT STORY
Chi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical Programs
PREV STORY
UPDATE – electroCore Appoints Multiple Industry Veterans to Key Management Positions
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

author_avatar
NASDAQ Market News

Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer

author_avatar
NASDAQ Market News

Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Research & Development

author_avatar
NASDAQ Market News